Escolar Documentos
Profissional Documentos
Cultura Documentos
(Parenteral)
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Therapeutic Uses:
Adverse Effects:
Contraindications/Precautions:
Interactions:
Anti-platelet agent
Education:
Treatment of Heparin OD
N203
ATI (Unit 7)
Hematologic System -
Adverse Effects:
Contraindications/Precautions:
Interactions:
Anticoagulant
(Oral)
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Pregnancy (X)
Contraindications/Precautions:
CI: Surgery of eye, brain, spinal cord; regional anesthesia; lumbar puncture
CI: PLT counts, uncontrolled bleeding, vit. K , liver problems, alcoholism
Heparin, aspirin, glucocorticoids bleeding
Interactions:
Acetaminophen, sulfonamides, parenteral cephalosporins, ASA [warfarin]
Phenobarbital, carbamazepine, phenytoin, OC, vitamin K warfarin effects
PT therapeutic level = 18-24 sec (normal = 11-12.5 sec)
Education:
Onset takes 8-12 hrs, full effect takes 3-5 days
Therapeutic Uses:
Treatment of Warfarin OD
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Therapeutic Uses:
Adverse Effects:
Contraindications/Precautions:
Interactions:
Education:
Antiplatelets
N203
ATI (Unit 7)
Hematologic System -
Expected
Action:
Interactions:
Medications that enhance bleeding additive risk for bleeding
Education:
ASA (81 mg) for prevention / ASA (325 mg) during initial acute MI episode
Thrombolytic Medications
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Proto: streptokinase
Others: alteplase (tPA), tenecteplase, reteplase
Adverse Effects:
Serious risk of bleeding from different sites
Streptokinase Hypotension (infuse slowly)
Allergic reaction or anaphylaxis
Hx of intracranial hemorrhage
Contraindications/Precautions:
Brain tumors / pericarditis / Recent head or facial trauma / internal bleeding
Interactions:
Meds that enhance bleeding have additive risk for bleeding
Admin within 4-6 hours of onset
Education:
IV aminocaproic acid for excessive fibrinolysis
Administer H2 antagonists such as ranitidine (Zantec) or PPI such as
omeprazole (Prilosec) to prevent GI bleeding.
Therapeutic Uses:
Iron Preparations
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Increase iron level for RBC development and oxygen transport capacity
Therapeutic Uses:
Adverse Effects:
Interactions:
Vitamin C
Antacids or tetracyclines
Education:
Vitamin B12
(Cyanocobalamin)
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Necessary to convert folate (required for DNA production) from inactive form
Treatment of B12 deficiency
Megaloblastic (macrocytic) anemia related to B12 deficiency
Therapeutic Uses:
Adverse Effects:
Contraindications/Precautions:
Interactions:
Education:
Folic Acid
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Folic acid is essential in DNA production & erythropoiesis (RBC, WBC, PLT)
Therapeutic Uses:
Tx of macrocytic anemia
Adverse Effects:
Contraindications/Precautions:
Interactions:
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Contraindications/Precautions:
Interactions:
Education:
Granulocyte Colony
Stimulating Factor
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Bone pain
Leukocytosis: dose / interrupt treatment if WBC > 50,000/cc, ANC >
20,000/cc, or platelets > 500,000/cc.
CI: Sensitive to E. coli proteins
Contraindications/Precautions:
Adverse Effects:
Interactions:
Education:
Granulocyte Macrophage
Colony Stimulating Factor
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Adverse Effects:
Education:
Thrombopoietic Growth
Factors
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Adverse Effects:
Dysrhythmias
Contraindications/Precautions:
Interactions:
Education:
Whole Blood
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Therapeutic Uses:
Adverse Effects:
Requires countersign
No Mix
Packed RBCs
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Therapeutic Uses:
# of RBCs
Erythroblastosis fetalis
Hemoglobinopathies
Med-induced hemolytic anemia
Requires countersign
No Mix
Platelet Concentrate
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Therapeutic Uses:
platelet count
Thrombocytopenia (< 20,000/cc)
Febrile nonhemolytic rxn (most common) (fever, headache): VS Q5m for 15m
Mild allergy: If respiration uncompromised, antihistamines and restart
Education:
Requires countersign
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Therapeutic Uses:
Extensive burns
Shock
Requires countersign
Pheresed Granulocytes
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Therapeutic Uses:
Neutrophil dysfunction
Adverse Effects:
Requires countersign
Albumin
N203
ATI (Unit 7)
Hematologic System -
Expected Action:
Therapeutic Uses:
Hypoalbuminemia
Burns